Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Bovine Insulin ELISA Kit (AC3467)
Cat.#: ASET-2056
Specifications
Description Bovine Insulin ELISA Kit allows for the in vitro quantitative determination of bovine Insulin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Bovine Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 4.688 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 7.813-500 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1297 Rat Myelin Basic Protein ELISA Kit (AC2708) Quantitative inquiry ASET-2342 Rat SCG10 ELISA Kit (AC3753) Quantitative inquiry ASET-2303 Human DCC ELISA Kit (AC3714) Quantitative inquiry ASET-1628 Human HAS3 ELISA Kit (AC3039) Quantitative inquiry ASET-1436 Rat Oxytocin Receptor ELISA Kit (AC2847) Quantitative inquiry ASET-1951 Mouse Midkine ELISA Kit (AC3362) Quantitative inquiry ASET-1618 Human Plexin B1 ELISA Kit (AC3029) Quantitative inquiry ASET-2182 Human Midkine ELISA Kit (AC3593) Quantitative inquiry ASET-2055 Mouse Glutamine Synthetase ELISA Kit (AC3466) Quantitative inquiry ASET-2033 Rat Agrin ELISA Kit (AC3444) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket